50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

Avita Medical's Recell Go mini gets FDA approval, stock rises over 6%

Published 12/23/2024, 04:51 PM
© Reuters.
RCEL
-

Investing.com -- Avita Medical (NASDAQ:RCEL)'s stock saw a post-market increase of over 6% on Monday, following the company's announcement that the US Food and Drug Administration (FDA) has given its approval to the premarket approval supplement for Recell Go mini.

This product is an addition to the firm's skin-repair product line. The Recell Go mini is a mini disposable cartridge, specifically designed to treat smaller wounds up to 480 square centimeters.

Avita Medical (TASE:PMCN) has stated that the rollout of Recell Go mini will commence with trauma and burn centers that currently treat smaller wounds.

“The FDA approval of Recell Go mini strengthens our ability to provide clinicians with fit-for-purpose solutions that meet the diverse needs of patients with full-thickness wounds,” Jim Corbett, the Chief Executive Officer of Avita Medical said in a press release.

The company expects this rollout to begin during the first quarter of 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.